DF/HCC Program Affiliation

Prostate Cancer
Kidney Cancer

Research Abstract

Christopher J. Sweeney, MBBS, is a Medical Oncologist at the Dana-Farber Cancer Institute. He is a member of the American Society of Clinical Oncology, the Eastern Cooperative Oncology Group, CALGB and the American Association for Cancer Research. Dr. Sweeney’s primary research interest is drug discovery and development. His academic focus is management of genitourinary malignancies, including prostate, bladder, testis and renal cell cancer. Dr. Sweeney is a highly active contributor to his field, having served on the Editorial Board for ASCO’s “Journal of Clinical Oncology” and the Program and Cancer Education Committees of the American Society of Clinical Oncology. He receives peer reviewed funding from the National Institutes of Health, the Department of Defense, and the Lance Armstrong Foundation. Dr. Sweeney is also a member of the Scientific Advisory Boards of biotech companies in the United States and Australia. Dr. Sweeney received his medical degree from the University of Adelaide, South Australia in 1992 and completed an internship at the Royal Adelaide Hospital. He did residency in internal medicine at Gundersen Lutheran Medical Center, La Crosse, Wisconsin and a fellowship in Hematology/Oncology at Indiana University Medical Center, where he was later appointed Associate Director for Clinical Research for the Simon Cancer Center. Dr. Sweeney joined the Lank Center for Genitourinary Oncology at DFCI and Harvard Medical School in 2009

Publications

View All Publications